Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.

FDA Recall Z-1561-2021 · Posted None

Recalling FirmRemel Inc
Recall StatusTerminated
Product CodeJSO
Date Initiated2021-04-22
Date Terminated2023-08-08
Product Quantity91/10-test units

Reason for Recall

The media allows growth of E. faecalis ATCC 29212 with blackening of the media.

Firm Action

The recalling firm issued customer letters dated 4/22/2021 via first class mail to its direct accounts.

Root Cause

Mixed-up of materials/components

Distribution Pattern

US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑